A self-administered screener for migraine in primary care

The ID migraine™ validation study

Richard B. Lipton, David William Dodick, R. Sadovsky, K. Kolodner, J. Endicott, J. Hettiarachchi, W. Harrison

Research output: Contribution to journalArticle

317 Citations (Scopus)

Abstract

Background: Migraine is a highly prevalent and disabling illness that remains substantially undiagnosed in primary care. Because of the potential value of a screening tool, the current study was designed to establish the validity and reliability of a brief, self-administered migraine screener in patients with headache complaints in the primary care setting. Methods: A total of 563 patients presenting for routine primary care appointments and reporting headaches in the past 3 months completed a self-administered migraine screener. All patients were then referred for an independent diagnostic evaluation by a headache expert, of whom 451 (80%) completed a full evaluation. Migraine diagnosis was assigned based on International Headache Society criteria after completing a semi-structured diagnostic interview. Results: Of nine diagnostic screening questions, a three-item subset of disability, nausea, and sensitivity to light provided optimum performance, with a sensitivity of 0.81 (95% CI, 0.77 to 0.85), a specificity of 0.75 (95% CI, 0.64 to 0.84), and positive predictive value of 0.93 (95% CI, 89.9 to 95.8). Test-retest reliability was good, with a kappa of 0.68 (95% CI, 0.54 to 0.82). The sensitivity and specificity of the three-item migraine screener was similar regardless of sex, age, presence of other comorbid headaches, or previous diagnostic status. Conclusions: The three-item ID Migraine™ migraine screener was found to be a valid and reliable screening instrument for migraine headaches. Its ease of use and operating characteristics suggest that it could significantly improve migraine recognition in primary care.

Original languageEnglish (US)
Pages (from-to)375-382
Number of pages8
JournalNeurology
Volume61
Issue number3
StatePublished - Aug 12 2003

Fingerprint

Validation Studies
Migraine Disorders
Primary Health Care
Headache
Reproducibility of Results
Photophobia
Nausea
Appointments and Schedules
Interviews
Sensitivity and Specificity

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Lipton, R. B., Dodick, D. W., Sadovsky, R., Kolodner, K., Endicott, J., Hettiarachchi, J., & Harrison, W. (2003). A self-administered screener for migraine in primary care: The ID migraine™ validation study. Neurology, 61(3), 375-382.

A self-administered screener for migraine in primary care : The ID migraine™ validation study. / Lipton, Richard B.; Dodick, David William; Sadovsky, R.; Kolodner, K.; Endicott, J.; Hettiarachchi, J.; Harrison, W.

In: Neurology, Vol. 61, No. 3, 12.08.2003, p. 375-382.

Research output: Contribution to journalArticle

Lipton, RB, Dodick, DW, Sadovsky, R, Kolodner, K, Endicott, J, Hettiarachchi, J & Harrison, W 2003, 'A self-administered screener for migraine in primary care: The ID migraine™ validation study', Neurology, vol. 61, no. 3, pp. 375-382.
Lipton RB, Dodick DW, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J et al. A self-administered screener for migraine in primary care: The ID migraine™ validation study. Neurology. 2003 Aug 12;61(3):375-382.
Lipton, Richard B. ; Dodick, David William ; Sadovsky, R. ; Kolodner, K. ; Endicott, J. ; Hettiarachchi, J. ; Harrison, W. / A self-administered screener for migraine in primary care : The ID migraine™ validation study. In: Neurology. 2003 ; Vol. 61, No. 3. pp. 375-382.
@article{0cb4bd54538640bdb6d1ec3672ec3033,
title = "A self-administered screener for migraine in primary care: The ID migraine™ validation study",
abstract = "Background: Migraine is a highly prevalent and disabling illness that remains substantially undiagnosed in primary care. Because of the potential value of a screening tool, the current study was designed to establish the validity and reliability of a brief, self-administered migraine screener in patients with headache complaints in the primary care setting. Methods: A total of 563 patients presenting for routine primary care appointments and reporting headaches in the past 3 months completed a self-administered migraine screener. All patients were then referred for an independent diagnostic evaluation by a headache expert, of whom 451 (80{\%}) completed a full evaluation. Migraine diagnosis was assigned based on International Headache Society criteria after completing a semi-structured diagnostic interview. Results: Of nine diagnostic screening questions, a three-item subset of disability, nausea, and sensitivity to light provided optimum performance, with a sensitivity of 0.81 (95{\%} CI, 0.77 to 0.85), a specificity of 0.75 (95{\%} CI, 0.64 to 0.84), and positive predictive value of 0.93 (95{\%} CI, 89.9 to 95.8). Test-retest reliability was good, with a kappa of 0.68 (95{\%} CI, 0.54 to 0.82). The sensitivity and specificity of the three-item migraine screener was similar regardless of sex, age, presence of other comorbid headaches, or previous diagnostic status. Conclusions: The three-item ID Migraine™ migraine screener was found to be a valid and reliable screening instrument for migraine headaches. Its ease of use and operating characteristics suggest that it could significantly improve migraine recognition in primary care.",
author = "Lipton, {Richard B.} and Dodick, {David William} and R. Sadovsky and K. Kolodner and J. Endicott and J. Hettiarachchi and W. Harrison",
year = "2003",
month = "8",
day = "12",
language = "English (US)",
volume = "61",
pages = "375--382",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - A self-administered screener for migraine in primary care

T2 - The ID migraine™ validation study

AU - Lipton, Richard B.

AU - Dodick, David William

AU - Sadovsky, R.

AU - Kolodner, K.

AU - Endicott, J.

AU - Hettiarachchi, J.

AU - Harrison, W.

PY - 2003/8/12

Y1 - 2003/8/12

N2 - Background: Migraine is a highly prevalent and disabling illness that remains substantially undiagnosed in primary care. Because of the potential value of a screening tool, the current study was designed to establish the validity and reliability of a brief, self-administered migraine screener in patients with headache complaints in the primary care setting. Methods: A total of 563 patients presenting for routine primary care appointments and reporting headaches in the past 3 months completed a self-administered migraine screener. All patients were then referred for an independent diagnostic evaluation by a headache expert, of whom 451 (80%) completed a full evaluation. Migraine diagnosis was assigned based on International Headache Society criteria after completing a semi-structured diagnostic interview. Results: Of nine diagnostic screening questions, a three-item subset of disability, nausea, and sensitivity to light provided optimum performance, with a sensitivity of 0.81 (95% CI, 0.77 to 0.85), a specificity of 0.75 (95% CI, 0.64 to 0.84), and positive predictive value of 0.93 (95% CI, 89.9 to 95.8). Test-retest reliability was good, with a kappa of 0.68 (95% CI, 0.54 to 0.82). The sensitivity and specificity of the three-item migraine screener was similar regardless of sex, age, presence of other comorbid headaches, or previous diagnostic status. Conclusions: The three-item ID Migraine™ migraine screener was found to be a valid and reliable screening instrument for migraine headaches. Its ease of use and operating characteristics suggest that it could significantly improve migraine recognition in primary care.

AB - Background: Migraine is a highly prevalent and disabling illness that remains substantially undiagnosed in primary care. Because of the potential value of a screening tool, the current study was designed to establish the validity and reliability of a brief, self-administered migraine screener in patients with headache complaints in the primary care setting. Methods: A total of 563 patients presenting for routine primary care appointments and reporting headaches in the past 3 months completed a self-administered migraine screener. All patients were then referred for an independent diagnostic evaluation by a headache expert, of whom 451 (80%) completed a full evaluation. Migraine diagnosis was assigned based on International Headache Society criteria after completing a semi-structured diagnostic interview. Results: Of nine diagnostic screening questions, a three-item subset of disability, nausea, and sensitivity to light provided optimum performance, with a sensitivity of 0.81 (95% CI, 0.77 to 0.85), a specificity of 0.75 (95% CI, 0.64 to 0.84), and positive predictive value of 0.93 (95% CI, 89.9 to 95.8). Test-retest reliability was good, with a kappa of 0.68 (95% CI, 0.54 to 0.82). The sensitivity and specificity of the three-item migraine screener was similar regardless of sex, age, presence of other comorbid headaches, or previous diagnostic status. Conclusions: The three-item ID Migraine™ migraine screener was found to be a valid and reliable screening instrument for migraine headaches. Its ease of use and operating characteristics suggest that it could significantly improve migraine recognition in primary care.

UR - http://www.scopus.com/inward/record.url?scp=0043126889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0043126889&partnerID=8YFLogxK

M3 - Article

VL - 61

SP - 375

EP - 382

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 3

ER -